EGA Institute for Women's Health


Prenatal Therapy

Professor Anna David leads a team developing prenatal treatment of severe early onset and life-threatening disorders using gene and cellular therapy, and to investigate the efficacy, safety and ethical issues of such treatment.


Research into fetal gene therapy began under a 5 year MRC Programme grant (Professor Charles Rodeck) in collaboration with the Gene Therapy Research Group (Professor Charles Coutelle) at Imperial College, London in 2000. Professor David obtained a PhD on clinically applicable methods of delivering fetal gene therapy in 2005 at UCL and she established the group in 2007.

Current projects
Dr Adalina Sacco

Dr Adalina Sacco

Clinical Lecturer & Sub-Specialty clinical trainee in Maternal & Fetal Medicine

MFM Research Students
Maternal and Fetal Adverse Event Terminatology: MFAET

Maternal & Fetal Adverse Event Terminology (MFAET)

A new system to provide better safety monitoring for clinical trials in pregnancy.